EIF5A2
Eukaryotic translation initiation factor 5A-2
Also known as: IF5A2_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9GZV4
- Gene
- EIF5A2
- Ensembl
- ENSG00000163577
- Chromosome
- 3
- Canonical length
- 153 aa
- Protein class
- Predicted intracellular proteins, Transporters
- Subcellular location
- Vesicles
OverviewNCBI Gene
Predicted to enable translation elongation factor activity. Predicted to be involved in translational elongation. Located in intracellular membrane-bounded organelle. [provided by Alliance of Genome Resources, Apr 2025]
Canonical amino-acid sequenceUniProt
153 residues, UniProt reviewed canonical sequence.
>Q9GZV4|EIF5A2
1 MADEIDFTTG DAGASSTYPM QCSALRKNGF VVLKGRPCKI VEMSTSKTGK HGHAKVHLVG
61 IDIFTGKKYE DICPSTHNMD VPNIKRNDYQ LICIQDGYLS LLTETGEVRE DLKLPEGELG
121 KEIEGKYNAG EDVQVSVMCA MSEEYAVAIK PCKLocalizationUniProt · AlphaFold · HPA
Whether an antibody against EIF5A2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.35
- Highest tissue expression
- 27 nTPM
Expression across tissuesHPA
Tissue
- testis: 27 nTPM
- stomach: 8.6 nTPM
- smooth muscle: 6.7 nTPM
- choroid plexus: 4.9 nTPM
- blood vessel: 4.8 nTPM
- cerebral cortex: 4.8 nTPM
Single-cell type
- late spermatids: 1,292 nCPM
- early spermatids: 380 nCPM
- parietal cells: 242 nCPM
- late primary spermatocytes: 187 nCPM
- melanocytes: 25 nCPM
- nk-cells: 20 nCPM
Immune cell
- basophil: 15 nTPM
- gdT-cell: 12 nTPM
- memory CD8 T-cell: 12 nTPM
- T-reg: 11 nTPM
- NK-cell: 8.8 nTPM
- MAIT T-cell: 8.7 nTPM
Brain region
- pons: 23 nTPM
- white matter: 20 nTPM
- medulla oblongata: 19 nTPM
- cerebral cortex: 18 nTPM
- cerebellum: 18 nTPM
- thalamus: 17 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.6
- gnomAD pLI
- 0
- gnomAD missense Z
- 1.24
- DepMap mean gene effect
- 0.12
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 9% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- positive regulation of translational elongation
- positive regulation of translational termination
- spermatogenesis
- translational elongation
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Translation elongation factor IF5A-like
- Translation protein SH3-like domain superfamily
- Nucleic acid-binding, OB-fold
- Large ribosomal subunit protein uL2, domain 2
- Translation initiation factor 5A, hypusine site
- Translation initiation factor 5A, C-terminal
- Translation initiation factor 5A-like, N-terminal
- Eukaryotic elongation factor 5A hypusine, DNA-binding OB fold
- Translation initiation factor 5A-like, N-terminal
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of EIF5A2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads EIF5A2 as an antibody target. Whether an autoantibody or antibody against EIF5A2 could matter depends on whether native EIF5A2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
EIF5A2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label EIF5A2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...